A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-07-19 / Clin. Cancer Res. 2017 Jan;23(2):399-406In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-05-14 / Cancers (Basel) 2016 May;8(5)Dendritic cell-based cancer immunotherapy for colorectal cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2016-05-07 / World J. Gastroenterol. 2016 May;22(17):4275-86Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-03-30 / Radiat Oncol J 2016 Mar;34(1):34-44Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 2016-01-11 / Int J Hyperthermia 2016;32(2):187-92Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-18Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
/in Colorectal Cancer, International Publications /von 2015-10-09 / Cytotherapy 2015 Dec;17(12):1746-62Enhancement of the Immunostimulatory Functions of Ex Vivo-Generated Dendritic Cells from Early-Stage Colon Cancer Patients by Consecutive Exposure to Low Doses of Sequential-Kinetic-Activated IL-4 and IL-12. A Preliminary Study
/in Colorectal Cancer, Dendritic Cells, International Publications /von 2015-08-01 / Transl Oncol 2015 Aug;8(4):327-38
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de